Former Site Leader and Vice President for Global Marketing at Medtronic/Covidien Vascular Therapies As a medical device leader and strategic marketing executive, Robert Rajalingam has been selected to lead Smith Medical’s $300 M Vascular Access business. Life Science Partner collaborated closely with Vice President, Carl Stamp to recruit Rajalingam from Medtronic. Vascular medicine has been […]
Former Senior Vice President, Chief Regulatory Officer at Medtronic As one of the foremost leaders in the complex regulatory arena of medical devices, combination products, and healthcare information, Susan Alpert, MD, PhD, has been recruited by Life Science Partner to serve as the top regulatory advisor for Canary Medical. Canary Medical has established an innovative […]
Congratulations to REVA Medical CEO and former Life Science Partner placement Reggie Groves on her feature in this week’s San Diego Business Journal! View the feature here.
Former Medical Director, Global Medical Marketing, ConvaTec Life Science Partner recruited Michel Hermans, MD, a surgically trained medical affairs executive to become Chief Medical Officer for TissueTech. Hermans joins TissueTech after serving as a biopharma consultant for his own firm and Medical Director, Global Medical Marketing for ConvaTech. Previously, Hermans served served as Medical Director […]
Former President and Chief Executive Officer of Vascular Pathways Life Science Partner has recruited Bill Bold, former CEO of Vascular Pathways and senior medical device leader, to become Chief Executive Officer for Vestagen, an innovator in the development of Active Barrier fabrics and protection technology to protect the healthcare worker. Prior to joining Vestagen, Bold turned […]
Former Senior Director, Global Safety Officer at The Medicines Company Life Science Partner recruited Yanshan Ma, MD, PhD, to become Senior Director, Medical Safety Physician, Internal Medicine and Infectious Diseases for Allergan. In her new role Dr. Ma will be responsible for the group’s safety strategy, pharmacovigilance and medical risk management. Dr. Ma joins Allergan […]
COLUMBIA, Md.–(BUSINESS WIRE)– Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, is pleased to announce the expansion of the management team with the appointment of Adrian Mollo as General Counsel and Dr. Jon Hopper as Chief Medical Officer, both reporting to Lode Debrabandere, […]
DANVERS, Mass., Oct. 08, 2015 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Seth Bilazarian, M.D. will be appointed as Vice President of Interventional Cardiology Programs, effective October 8, 2015. “We are excited to welcome Dr. Seth Bilazarian to Abiomed, where he will add a specialized interventional […]
Former Chief Medical Officer Rosetta Genomics Life Science Partner recruited Bob Wassman, MD, to become Chief Medical Officer of Lineagen to lead The Company’s clinical direction, product strategy, medical affairs, and global trials and registration process for Lineagen’s products and services. Previously, as Chief Medical Officer for Rosetta Genomics, Wassman played a critical role in […]
Former Senior Director, Research and Development At Genzyme/Sanofi Life Science Partner has recruited Gloria Matthews, DVM, PhD to become Chief Medical Officer at Histogenics. In her new role Matthews will report directly to the Chief Executive Officer, Adam Gridley, and will serve as the senior physician within Histogenics responsible for clinical direction, product strategy, medical […]